Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8721L |
I-37 free base( 2359690-13-2(free base))
|
Raf | MAPK |
I-37 free base( 2359690-13-2(free base)) 是一种新型苄氨基取代的吡啶并嘧啶酮,可作为 SOS1 抑制剂。 | |||
T8721 |
I-37
Pyrido[4,3-d]pyrimidin-7(6H)-one, 2-methyl-6-(1-methylcyclopropyl)-4-[[(1R)-1-[2-methyl-3-(trifluoromethyl)phenyl]ethyl]amino]- |
Raf | MAPK |
I-37 (Pyrido[4,3-d]pyrimidin-7(6H)-one, 2-methyl-6-(1-methylcyclopropyl)-4-[[(1R)-1-[2-methyl-3-(trifluoromethyl)phenyl]ethyl]amino]-) 是一种新型苄氨基取代的吡啶并嘧啶酮,可作为 SOS1 抑制剂。 | |||
T35003 |
UR-PI376
UR-PI 376,UR-PI-376,URPI-376,URPI 376 |
||
UR-PI376 is a histamine H4 receptor agonist (hH4R agonist) (pEC50 = 7.47, alpha = 0.93), with low activity for hH1R and hH2R and significant selectivity for hH3R (pKB = 6.00, alpha =- 0.28), as in stable-use a membrane preparation of hH(x)R-expressing Sf9 | |||
T36733 |
HLI373 dihydrochloride
|
||
HLI373 dihydrochloride is a potent Hdm2 inhibitor, efficiently restraining the ubiquitin ligase activity of Hdm2 and effectively prompting apoptosis in DNA-damaging agent-sensitive tumor cells[1]. Additionally, HLI373 dihydrochloride exhibits antimalarial activity[2]. |